Loading...
Loading...
Smart Money Score
Composite context from Form 4, 13F and congressional disclosures; not a forecast.
Holder clone rankings through .
Of the 16 tracked institutions holding BCRX, 6 have a 3-year clone track record — 4 of them beat the S&P. Average holder's clone alpha: +2.1pt. It's a gauge of who owns the name, not just how many.
Among the 16 tracked institutional investors we monitor, BCRX (BIOCRYST PHARMACEUTICALS INC) is held with a combined value of $610.46M across 74,961,995 shares. The largest holder is BlackRock, Inc. with a position worth $202.71M. 8 funds increased their holdings. 8 funds reduced their position.
Total Institutional Value
$610.46M
Total Shares Held
74,961,995
Institutional Holders
16
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $202.71M | 0.00% | +1.8% |
| 2 | VANGUARD GROUP INC | $173.73M | 0.00% | +2.2% |
| 3 | STATE STREET CORP | $102.41M | 0.00% | -19.1% |
| 4 | TWO SIGMA ADVISERS, LP | $31.90M | 0.06% | -3.6% |
| 5 | Fisher Asset Management, LLC | $20.40M | 0.01% | -6.0% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $17.21M | 0.02% | -18.3% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | $11.81M | 0.00% | +363.5% |
| 8 | AQR CAPITAL MANAGEMENT LLC | $10.61M | 0.00% | -42.5% |
| 9 | MILLENNIUM MANAGEMENT LLC | $9.77M | 0.01% | -65.4% |
| 10 | FMR LLC | $7.76M | 0.00% | +15.2% |
| Member | Type | Date |
|---|---|---|
| Gilbert Cisneros | Buy | Jul 10, 2026 |
| Gilbert Cisneros | Buy | Nov 13, 2025 |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of BCRX with a position worth $202.71M, representing 0.00% of their portfolio. In total, 16 institutional investors hold BCRX with a combined value of $610.46M.
Institutional investors hold $610.46M worth of BCRX stock across 16 positions. The largest institutional holder is BlackRock, Inc. with $202.71M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For BCRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| — |
| 4.8% |
| 2026-11-10 |
| — | 6.2% | 2026-08-14 |
| — | 6.0% | 2026-08-07 |
SEC Schedule 13D (activist) and 13G (passive) filings for BCRX. Filed when an investor acquires 5%+ ownership.
Last Close
$7.50
2026-11-17
YTD
+0.0%
26% of 52-week range